A PHASE II CLINICAL TRIAL OF IMMUNOTHERAPY WITH ANTI-PD-1 ANTIBODY (NIVOLUMAB) IN ADVANCED/RELAPSED, PLATINUM-RESISTANT OVARIAN CANCER

被引：0
|
作者：
Hamanishi, J. [1 ]
Mandai, M. [2 ]
Matsumura, N. [1 ]
Abiko, K. [1 ]
Baba, T. [1 ]
Yamaguchi, K. [1 ]
Ueda, M. [1 ]
Horikawa, N. [1 ]
Murakami, R. [1 ]
Koshiyama, M. [1 ]
Konishi, I. [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[2] Kinki Univ, Grad Sch Med, Kyoto, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-1133
引用
收藏
页码：400 / 401
页数：2
相关论文
共 50 条
  • [1] Durable anti-tumor response of nivolumab (anti-PD-1 antibody) for platinum-resistant ovarian cancer; phase II clinical trial with nivolumab
    Hamanishi, J.
    Mandai, M.
    Matsumura, N.
    Abiko, K.
    Baba, T.
    Yamaguchi, K.
    Konishi, I.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 137 : 23 - 23
  • [2] CHEMOSENSITIVITY AFTER ANTI-PD-1 ANTIBODY NIVOLUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER
    Inayama, Y.
    Hamanishi, J.
    Matsumura, N.
    Murakami, R.
    Abiko, K.
    Yamaguchi, K.
    Baba, T.
    Horie, K.
    Konishi, I.
    Mandai, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 709 - 709
  • [3] Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
    Hamanishi, Junzo
    Mandai, Masaki
    Ikeda, Takafumi
    Minami, Manabu
    Kawaguchi, Atsushi
    Murayama, Toshinori
    Kanai, Masashi
    Mori, Yukiko
    Matsumoto, Shigemi
    Chikuma, Shunsuke
    Matsumura, Noriomi
    Abiko, Kaoru
    Baba, Tsukasa
    Yamaguchi, Ken
    Ueda, Akihiko
    Hosoe, Yuko
    Morita, Satoshi
    Yokode, Masayuki
    Shimizu, Akira
    Honjo, Tasuku
    Konishi, Ikuo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 4015 - +
  • [4] Innovative cancer immunotherapy, anti-PD-1 antibody Nivolumab
    Shibayama, Shiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S40 - S40
  • [5] Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer.
    Hamanishi, Junzo
    Mandai, Masaki
    Ikeda, Takafumi
    Minami, Manabu
    Kawaguchi, Atsushi
    Matsumura, Noriomi
    Abiko, Kaoru
    Baba, Tsukasa
    Yamaguchi, Ken
    Ueda, Akihiko
    Kanai, Masashi
    Mori, Yukiko
    Matsumoto, Shigemi
    Murayama, Toshinori
    Chikuma, Shunsuke
    Morita, Satoshi
    Yokode, Masayuki
    Shimizu, Akira
    Honjo, Tasuku
    Konishi, Ikuo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] A phase II trial of voreloxin in women with platinum-resistant ovarian cancer
    Hirte, H. W.
    McGuire, W.
    Edwards, R.
    Husain, A.
    Hoskins, P.
    Michels, J.
    Matulonis, U.
    Sexton, C.
    Michelson, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] EFFICACY AND SAFETY OF AK112, AN ANTI-PD-1/VEGFA BISPECIFIC ANTIBODY, IN PATIENTS WITH PLATINUM-RESISTANT/REFRACTORY EPITHELIAL OVARIAN CANCER IN A PHASE 1 STUDY
    Coward, Jermaine
    Frentzas, Sophia
    Mislang, Anna
    Gao, Bo
    Lemech, Charlotte
    Jin, Xiaoping
    Li, Baiyong
    Wang, Max
    Kwek, Kon Yew
    Zhou, Yiting
    Xia, Yu
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A457 - A457
  • [8] Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer
    Walsh, Christine S.
    Kamrava, Mitchell
    Rogatko, Andre
    Kim, Sungjin
    Li, Andrew
    Cass, Ilana
    Karlan, Beth
    Rimel, Bobbie J.
    [J]. PLOS ONE, 2021, 16 (06):
  • [9] A phase II study of irinotecan and docetaxel in patients with platinum-resistant relapsed epithelial ovarian cancer
    Matsumoto, T.
    Hiura, M.
    Oshita, T.
    Hirata, E.
    Shiroyama, Y.
    Wroblewski, J.
    Yokoyama, T.
    Nogawa, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or - Refractory Ovarian Cancer
    Liu, Joyce F.
    Ray-Coquard, Isabelle
    Selle, Frederic
    Poveda, Andres M.
    Cibula, David
    Hirte, Hal
    Hilpert, Felix
    Raspagliesi, Francesco
    Gladieff, Laurence
    Harter, Philipp
    Siena, Salvatore
    del Campo, Josep Maria
    Tabah-Fisch, Isabelle
    Pearlberg, Joseph
    Moyo, Victor
    Riahi, Kaveh
    Nering, Rachel
    Kubasek, William
    Adiwijaya, Bambang
    Czibere, Akos
    Naumann, R. Wendel
    Coleman, Robert L.
    Vergote, Ignace
    MacBeath, Gavin
    Pujade-Lauraine, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4345 - +
12345